Researchers at the University of Tennessee Health Science Center working with colleagues at the University of New Mexico have identified three drugs, already approved for other uses in humans, as possible therapeutics for COVID-19, the illness caused by the SARS-CoV-2 virus. Based on virtual and in vitro antiviral screening that began in the earlier months of… Read More
For the second year, the Master of Science in Pharmacology Program in the UTHSC College of Graduate Health Sciences has ranked Number 5 of 25 in Best Value according to a listing by BestValueSchools.com. “This is a great honor, indeed,” said Alex Dopico, MD, PhD, Chair of Excellence and professor in the Department of Pharmacology,… Read More
Artificial intelligence (AI) has steadily become a part of our everyday lives. Over the past several years, AI is increasingly being applied to biomedical research and in clinical care, however current methods being used in developing AI for biomedical research and clinical decisions may generate new health care disparities. In the paper published recently in… Read More
The University of Tennessee Health Science Center has entered into an agreement with the Regeneron Genetics Center, a subsidiary of Regeneron Pharmaceuticals, Inc., for the company to sequence DNA that has been voluntarily provided and stored as part of a biorepository initiative UTHSC is building in collaboration with its partner teaching hospitals. The collaboration is… Read More
The University of Tennessee Health Science Center’s College of Medicine has formed the UTHSC Cancer Program, a new comprehensive, multidisciplinary initiative consisting of a group of university faculty clinicians, who will provide cancer care across multiple university-affiliated hospital systems and clinical practice groups in the region. The new program includes physicians in all cancer-related specialties… Read More
In humans, large arteries lose elasticity and thicken with age and other pathological conditions, leading to arteriosclerosis and high blood pressure. Age-related arterial stiffening affects a large population and is a major risk factor for cardiovascular disease, yet it remains poorly understood, with no effective intervention. Work being done in the lab of Zhongjie Sun,… Read More
In the transition from fetal to neonatal life, the kidneys undergo delicate and intricate changes in functionality as they assume the primary responsibility for keeping the blood clean and chemically balanced. Understanding these complex physiological changes is critical, as stressors before, during, and after delivery put newborns at risk of kidney injury and maladaptation. The… Read More
Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville and director of the Amyloidosis and Cancer Theranostics, has been awarded a two-year grant totaling $385,000 from the National Institute on Aging, part of the National Institutes of Health to study new treatments for systemic amyloidosis. “Our… Read More
